Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada.
| Revenue (Most Recent Fiscal Year) | $924.22M |
| Net Income (Most Recent Fiscal Year) | $-9.42M |
| PE Ratio (Current Year Earnings Estimate) | 12.55 |
| PE Ratio (Trailing 12 Months) | 13.25 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 1.14 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.39 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 4.65 |
| Pre-Tax Margin (Trailing 12 Months) | -56.10% |
| Net Margin (Trailing 12 Months) | -53.56% |
| Return on Equity (Trailing 12 Months) | 2.69% |
| Return on Assets (Trailing 12 Months) | 1.82% |
| Current Ratio (Most Recent Fiscal Quarter) | 3.91 |
| Quick Ratio (Most Recent Fiscal Quarter) | 2.45 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.33 |
| Inventory Turnover (Trailing 12 Months) | 2.34 |
| Book Value per Share (Most Recent Fiscal Quarter) | $14.52 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.08 |
| Earnings per Share (Most Recent Fiscal Year) | $0.45 |
| Diluted Earnings per Share (Trailing 12 Months) | $-2.23 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Common Shares Outstanding | 217.04M |
| Free Float | 214.59M |
| Market Capitalization | $1.04B |
| Average Volume (Last 20 Days) | 5.27M |
| Beta (Past 60 Months) | 1.84 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 1.13% |
| Percentage Held By Institutions (Latest 13F Reports) | 96.73% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |